Copyright
©The Author(s) 2024.
World J Psychiatry. Aug 19, 2024; 14(8): 1148-1164
Published online Aug 19, 2024. doi: 10.5498/wjp.v14.i8.1148
Published online Aug 19, 2024. doi: 10.5498/wjp.v14.i8.1148
Psychiatric disorder | Machine learning method | Datatypes | Dataset features | Findings | Ref. |
Bipolar disorder | Decision tree, random forest | Gene expression | RBPMS2, LILRA5 (male responders); ABRACL, FHL3, NBPF14 (female responders) | Predicted lithium responders in bipolar patients with AUC = 0.92 | Eugene et al[36] |
Major depressive disorder | ARPNet model-linear regression | SNPs, DNA methylation, demographic | Neuroimaging biomarkers, Genetic variants, DNA methylation, demographic information | Predicted the most effective antidepressant with 84% accuracy | Chang et al[37] |
Major depressive disorder | Deep learning-MFNNs | SNPs, demographic, clinical | Genome-wide associations, marital status, age, sex, suicide attempt status, baseline hamilton rating scale for depression score, depressive episodes | Conducted GWAS to identify SNP associations with antidepressant treatment response and remission. MFNN models achieved high accuracy (AUC = 0.82 for response, AUC = 0.81 for remission). | Lin et al[39] |
Major depressive disorder | Tree-based ensemble structure | Clinical, demographic | Clinical variables (patients with depression from STAR*D) | Predicted clinical antidepressant remission with 59% accuracy | Chekroud et al[40] |
Major depressive disorder | Elastic net | Clinical, demographic | Clinical variables: Patients with major depressive disorder (GENDEN participants) | Forecasted antidepressant response with AUC = 0.72 | Iniesta et al[41] |
Treatment-resistant depression | Random forest | SNPs, clinical | SNP (rs6265 (BDNF gene), rs6313 (HTR2A gene), rs7430 (PPP3CC gene), Clinical variable - Melancholia | Predicted antidepressant treatment outcome with 25% accuracy | Kautzky et al[42] |
Major depressive disorder | SVM, decision trees | SNPs | rs2036270 SNP (RARB gene), rs7037011 SNP (LOC105375971 gene) | Estimated antidepressant treatment response with 52% accuracy | Maciukiewicz et al[43] |
Bipolar disorder | Random forest | Clinical | Clinical variables (patients with bipolar disorder treated primarily with lithium) | Predicted responders for lithium treatment outcome with AUC = 0.8 | Nunes et al[44] |
Late-life depression | Alternating decision tree | Clinical, demographic | Mini-mental status examination scores, age, structural imaging | Predicted antidepressant treatment response with 89% accuracy | Patel et al[45] |
Major depressive disorder | Random forest | SNPs | SNPs (rs5743467, rs2741130, rs2702877, rs696692, rs17137566, rs10516436) | Predicted antidepressant therapy response with AUC > 0.7 and accuracy > 69% | Athreya et al[46] |
- Citation: Okpete UE, Byeon H. Challenges and prospects in bridging precision medicine and artificial intelligence in genomic psychiatric treatment. World J Psychiatry 2024; 14(8): 1148-1164
- URL: https://www.wjgnet.com/2220-3206/full/v14/i8/1148.htm
- DOI: https://dx.doi.org/10.5498/wjp.v14.i8.1148